APL is considered a promyelocytic leukemia protein (PML)-retinoic acid receptor-a (RARa) derived cancer, and the majority of APL cases are induced by a specific t(15,17) chromosomal translocation encoding the PML–RARα fusion protein (de Thé, 2018). This evidence concerns the gene RARA and acute promyelocytic leukemia.